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Edited by Peter BrzezinskiAbstract Cell-penetrating peptides (CPPs) are able to translo-
cate across biological membranes and deliver bioactive proteins.
Cellular uptake and intracellular distribution of CPPs is com-
monly evaluated with ﬂuorescent labels, which can alter peptide
properties. The eﬀect of carboxyﬂuorescein label in the Lys-rich
domain of the amphipathic CPP pep-1, was evaluated and com-
pared with non-labelled pep-1 in vitro and in vivo. A reduced
membrane aﬃnity and an endosomal-dependent translocation
mechanism, at variance with non-labelled pep-1, were detected.
Therefore, the charged domain is not a mere enabler of peptide
adsorption but has a crucial role in the translocation pathway
of non-labelled pep-1.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The discovery of various basic peptides (9–33 amino acid
residues) with ability to translocate across cell membranes
has attracted much interest in biomedical research [1]. These
peptides, known as cell-penetrating peptides (CPPs), have been
successfully used to deliver biopharmaceutical macromolecules
in vivo. The use of such delivery systems is of great interest to
evade the poor cellular access and bioavailability of drugs [2].
The translocation mechanism used by this group of carriers
has been extensively studied in the last 10 years, but the results
are frequently contradictory and disperse. A single general
mechanism for all does not seem reasonable and more than
one mechanism for a unique peptide is a possibility [3,4]. To
evaluate the cellular uptake and intracellular distribution of
CPP, ﬂuorescent labels are commonly used. However, whenAbbreviations: CPP, cell-penetrating peptide; CF, carboxyﬂuorescein;
b-Gal, b-galactosidase; MUG, 4-methylumbelliferyl-galactoside; TX-
100, Triton X-100; TB, trypan blue; POPC, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine; POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-
(phospho-rac-(1-glycerol)); 5DS, 5-doxyl-stearic acid; 16DS, 16-doxyl-
stearic acid; MEME, minimum essential medium Eagles; LUVs, large
unilamellar vesicles; 4-MU, 4-methylumbelliferone
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doi:10.1016/j.febslet.2005.06.085these labels are large and lipophilic they may alter physico-
chemical properties and the cellular distribution of the peptide
[5].
Pep-1 (Ac-KETWWETWWTEWSQPKKKRKV-cystea-
mine) is a synthetic peptide carrier forming physical assemblies
with a great variety of proteins and other macromolecules,
which have been successfully translocated in diﬀerent cell lines
[6–10]. It has been shown that pep-1 translocates across mem-
branes by a physical process mediated by transmembrane po-
tential, both in vitro and in vivo, in free form [11] or when
complexed with a protein, with no evidence for an alternative
mechanism [7]. Because the translocation is solely physically
mediated, the hydrophobicity and charge distribution of the
peptide and its interaction with membranes is of ﬁrst impor-
tance. The amphipathicity of the carrier is probably responsi-
ble by the strong interaction with the lipidic membranes [12].
Unlike other cationic CPPs (e.g., penetratin) [13] pep-1 has a
high aﬃnity for neutral vesicles and for membranes in gel-like
phase. The presence of cysteamine group in C terminal seems
to play a crucial role in the delivery eﬃciency of cargoes into
cells [12].
In the present paper, the study of a modiﬁed peptide with a
carboxyﬂuorescein probe (pep-1CF) is compared with pep-1.
In this peptide, the hydrophilic domain (KKKRKV-cyste-
amine) has been customized to accommodate the label. An ex-
tra Lys was introduced to link the probe and C terminal is
blocked with a Ser instead of cysteamine to avoid steric con-
straints (KKRKVK(CF)-S). The eﬀect of the alteration intro-
duced in this hydrophilic domain in the translocation
mechanism is presented, using both the Trp residues and CF
moiety as reporters of the so-called hydrophobic and hydro-
philic domains, respectively.2. Materials and methods
Pep-1 and Pep-1CF with purity >95% were obtained from
GenScript Corporation, New Jersey. b-Galactosidase from Esche-
richia coli (b-Gal), 4-methylumbelliferyl-galactoside (MUG), Triton
X-100 (TX-100) and trypan blue (TB) were obtained from Sigma–
Aldrich, MO. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))
(POPG), were from Avanti Polar-Lipids, Alabama. 5-Doxyl-stearic
acid (5DS) and 16-doxyl-stearic acid (16DS) from Aldrich Chem
Co., WI. Minimum essential medium Eagles with Earles salts
(MEME) and supplements were obtained from Gibco Invitrogen
Corporation, CA.blished by Elsevier B.V. All rights reserved.
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Pep-1CF solutions were prepared in HEPES buﬀer (10 mM HEPES,
pH 7.4 containing 10 mM (low ionic strength) or 150 mM NaCl (the
so-called physiologic ionic strength)). The assays were performed at
room temperature in a UV–Vis spectrophometer Jasco V-560 and in
a spectroﬂuorometer SLM Aminco 8100. Fluorescence intensity values
were corrected for inner ﬁlter eﬀect [14].
The absorption and ﬂuorescence emission characteristics of the
hydrophobic domain (by means of Trp ﬂuorescence; kexc = 280 nm,
kem = 350 nm) and of the hydrophilic domain (by CF group;
kexc = 490 nm, kem = 520 nm), were studied. Quantum yield-depen-
dence on peptide concentration (0–18 lM) and ionic strength (by
means of NaCl concentration variation) were also evaluated. Fluores-
cence quenching of Trp residues by acrylamide was carried out using
kexc = 290 nm to minimize the relative quencher/ﬂuorophore light
absorption ratio. Quenching data were corrected as described in [12].2.2. Interaction of pep-1CF with model membranes
Large unilamellar vesicles (LUVs), with typical 100 nm diameter
were prepared by the extrusion method described elsewhere [15] and
used as model of biological membranes. Liquid-crystal phase vesicles
composed by POPC or POPC:POPG (4:1 molar) were used to model
the outer leaﬂet (neutral) and the inner leaﬂet (negatively charged) of
mammals biological membranes [16]. The extent and kinetics of parti-
tion and the in-depth location of pep-1CF were evaluated using the
same procedure as for pep-1 [12]. Both hydrophobic and hydrophilic
domains were studied.
The DiSBAC2(3) dye is a probe with a higher aﬃnity for depolarized
than polarized membranes and its apparent quantum yield being
dependent on the extent of interaction with membranes [17]. These
ﬂuorescence properties were used to evaluate alterations in transmem-
brane potential of model membranes upon addition of pep-1CF. Ves-
icles in the absence and presence of a negative transmembrane
potential were prepared as described in [11]; DiSBAC2(3) was added
to lipidic suspension to a ﬁnal concentration of 0.25 mM and ﬂuores-
cence emission intensity (kexc = 540 nm, kem = 558 nm) was followed
during titration of lipidic suspension with pep-1CF (576 lM stock
solution) or non-labelled pep-1 (688 lM stock solution).2.3. Translocation studies of pep-1CF in HeLa cells
Adherent human negroid cervix epitheloid carcinoma cells (HeLa)
were grown in MEME supplemented with 2 mM L-Glu, 2 mM non-
essential aminoacids, 10% (v/v) fetal bovine serum and 1% (v/v)
streptomycin and penicillin, in a 5% CO2 humidiﬁed atmosphere
at 37 C. Cell viability was determined by the TB exclusion assay,
see [7].
The translocation of pep-1CF and it capacity to mediate the uptake
of b-Gal were followed in non-ﬁxation conditions. Cells with 90% con-
ﬂuence, seeded in 96-well plates, were incubated with 40 lL of 3.5 lM
pep-1CF, (in free or complexed form with b-Gal (peptide/protein ratio
of 320), prepared in free-serum medium), in sixplicates, during 0, 30,
60, 90, 120, 150, 180, 210 and 240 min at 4 or 37 C.
The quencher properties of TB and it inability to enter in viable cells
[18] were used to evaluate the pep-1CF translocation. This hydrophilic
molecule is able to quench non-internalized particles, including the
fraction adsorbed to the cell membrane, but is inaccessible to internal-
ized fraction [19], so removal of extracellular peptide is needless. The
pep-1CF ﬂuorescence was followed, before and after addition of TB
(1.9 lL of stock solution, 0.4% w/v), with excitation and emission ﬁl-
ters at 485/20 (centre/width) and 590/35 nm, respectively, in a FL500
microplate ﬂuorescence reader. To evaluate the eﬀect of protein in
the extension of peptide internalization, the same procedure was fol-
lowed with pep-1CF complexed.
Delivery eﬃciency of b-Gal mediated by pep-1CF was evaluated by
it enzymatic activity using a non-ﬂuorescent substrate (MUG) which is
converted in a ﬂuorescent product (4-methylumbelliferone, 4-MU), see
[7] for a detailed description. Brieﬂy, after incubation with pep-1CF/b-
Gal complex (see above), cells were washed three times with phosphate
buﬀer saline solution to eliminate non-incorporated protein and pep-
tide. Internalized b-Gal was accessed after cell permeabilization with
0.1% (w/v) TX-100. Substrate (0.1 mM MUG) was added to the cells
and incubated with the enzyme during 30 min at 37 C. NaOH was
added to stop the reaction (pH  12) and product formation (4-MU)
was monitored with excitation and emission ﬁlters at 360/40 and460/40 nm, respectively. The same procedure was performed with
non-labelled peptide. Controls without pep-1 or pep-1CF were carried
out.
The eﬀect of peptide in the protein was determined by comparing it
enzymatic activity in free and complexed forms (with non-labelled pep-
1 or pep-1CF) in vitro (see [7]).3. Results and discussion
3.1. Pep-1CF aggregates in aqueous solution
Similarly to non-labelled pep-1 [12], Trp residues in the
hydrophobic domain of pep-1CF, have a red-edge excitation
shift and an eﬃcient ﬂuorescence quenching by acrylamide
(51.8 ± 12 and 42.1 ± 9.1 M1 for low and physiologic ionic
strength, respectively) with a negative deviation from linearity.
These results indicate that the peptide aggregates in solution
(see [12]). Nevertheless, the quantum yield and steady-state
anisotropy of the CF group in hydrophilic domain is not
dependent on concentration, for both ionic strengths (10 and
150 mM), which suggests that internal organization of the pep-
tide is not aﬀected by these factors.
3.2. Partition and in-depth location of pep-1CF in model
membranes
Aﬃnity of hydrophobic and hydrophilic domains for lipidic
membranes was evaluated by titration of an aqueous suspen-
sion of the pep-1CF (5.76 lM) with lipidic vesicles; both Trp
and CF ﬂuorescence emission were monitored. Spectral altera-
tions on ﬂuorescence emission and anisotropy (r = 0.05) were
not detected, either for POPC or POPC:POPG (4:1) LUVs.
These results suggest that the hydrophilic domain does not
strongly interact with model membranes. When Trp residues
were followed, the addition of lipidic suspension led to both
blue-shifted emission spectra (Fig. 1A) and an increase in the
ﬂuorophore quantum yield (Fig. 1B). The partition coeﬃcients
(determined by ﬂuorescence emission intensity as in [12]) are
(4.2 ± 0.8) · l02 for POPC and (1.7 ± 0.2) · l03 for POPC:-
POPG (4:1) at physiologic ionic strength. These values are sig-
niﬁcantly smaller than the ones obtained for non-labelled pep-1
((3.4 ± 0.6) · l03 and (2.8 ± 0.4) · l04 [12]), which indicates a
decrease in membrane aﬃnity even for the hydrophobic do-
main. Concomitantly, partition rates decrease (t1/2 = 197 ms
in POPC and 147 ms in POPC:POPG (4:1) for pep-1CF in com-
parison with 120 and 34 ms, respectively, for unlabelled pep-1).
An extensive ﬂuorescence emission quenching of Trp resi-
dues by acrylamide, in the presence of lipidic membranes, is
indicative of signiﬁcant amounts of peptide non-inserted in
the membrane, at discrepancy with pep-1 in the same condi-
tions where no signiﬁcant acrylamide quenching was detected
[12].
In-depth location of the hydrophobic domain of pep-1CF
was carried out by means of ﬂuorescence quenching of Trp res-
idues with doxyl-derivatized stearic acids. The quenching is
more eﬃcient when the quencher is closer to the Trp residues.
Therefore, 5DS probes the bilayer interface while 16DS probes
its core [20]. Quenching by 5DS is more eﬃcient than by 16DS,
this is true for POPC (KSV,5DS = 16.1 ± 3.8 M
1, KSV,16DS =
5.2 ± 0.9 M1) and POPC:POPG (4:1) (KSV,5DS = 15.3 ±
3.5 M1, KSV,16DS = 4.9 ± 1.0 M
1). This is evidence for a
position of the hydrophobic region at the membrane interface
in both lipidic systems studied. The same conclusion was ob-
tained in the study of non-labelled pep-1 [12].
Fig. 1. Partition of Pep-1CF-hydrophobic domain in POPC LUVs
(kcxc = 280 nm). (A) shifting of pep-1CF ﬂuorescence emission spectra
with lipidic concentration (0–3.75 mM). (B) Fluorescence intensity
emission maximum dependence on lipidic concentration.
Fig. 2. Variation of transmembrane potential in POPC LUVs by
titration with pep-1CF in absence (1) or presence of transmembrane
potential (2) or with non-labelled pep-1 in presence of transmembrane
potential (3). Monitored with DiSBAC2(3) ﬂuorescence emission
(kexc = 540 nm, kem = 558 nm) (inserts indicate addition of 5lL from
pep-1CF or pep-1 stock solution).
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supporting the hypothesis that the hydrophilic domain does
not insert in the membrane.
3.3. Translocation of pep-1 and pep-1CF in LUVs is dependent
on transmembrane potential
To evaluate pep-1CF translocation in model membranes, the
ﬂuorescence of DiSBAC2(3) was followed. The quantum yield
of the probe increases with depolarization of membranes.
Titration of POPC LUVs (in absence (1) or presence (2) of
transmembrane potential) with pep-1CF is presented in
Fig. 2. The variation of probe ﬂuorescence emission diﬀers
for the two situations (with/without potential). When trans-
membrane potential exists the addition of pep-1CF induces
an increase in ﬂuorescence intensity, so membrane is depolar-
ized. In the absence of a transmembrane potential a decrease
quantum yield was detected, which indicates a polarization
of membrane.
These results suggest that in the absence of transmembrane
potential the peptide accumulates in the outer leaﬂet of mem-
brane, without translocation. The positive global charge of
pep-1CF is responsible by membrane polarization.
In the presence of a transmembrane potential (negative
inside) pep-1CF is able to translocate across membrane, reduc-ing the negative transmembrane potential, with an increase in
quantum yield of DiSBAC2(3).
Similar results were obtained with non-labelled pep-1 using
this (Fig. 2, curve (3)) and other methodologies [11], but the
eﬀect of a negative transmembrane potential is more pro-
nounced, which suggest that pep-1 has a more eﬃcient translo-
cation than pep-1CF. This is expected considering the lower
aﬃnity of pep-1CF for phospholipids membranes.
3.4. Translocation kinetic of pep-1CF and pep-1CF/b-Gal in
HeLa cells
Translocation of pep-1CF in HeLa cells was evaluated at 4
and 37 C (Fig. 3) by the use of TB quenching properties. Its
capacity to interact with the CF dye and to quench its ﬂuores-
cence emission was used to distinguish internalized from sur-
face-bound pep-1CF [18]. The quenching extent is decreased
when the peptide translocates across cell membranes and
become inaccessible to the quencher.
At 37 C, we observed ﬂuorescence recovery up to 240 min
incubation at variance with results at 4 C where the ﬂuores-
cence intensity remained unchanged during the same time
(Fig. 3A). This suggest that translocation of pep-1CF occurs
via endocytosis. Recently, it has been found that two N-termi-
nally CF-labelled CPPs are internalized by HeLa cells via raft-
mediated endocytosis [21].
Signiﬁcant diﬀerences in the kinetics of translocation, for
free (Fig. 3A) or complexed (Fig. 3B) forms, of Pep-1CF were
not detected.
The uptake of the b-Gal cargo itself, at 4 and 37 C, was
evaluated by following the enzymatic hydrolysis, of a non-ﬂuo-
rescent substrate (MUG) to a ﬂuorescent product (4-MU). The
hydrolysis step is carried out at 37 C after the translocation
incubation step. We observed that the translocated protein
was active and that the uptake of protein was much more eﬃ-
cient at 37 C than at 4 C (180 min after incubation the ﬂuo-
rescence emission intensity of 4-MU was found to be 14.5
times higher at 37 C relative to 4 C).
In order to investigate the eﬀect of CF-derivatization in pep-
tide translocation, we compared the eﬃciency of b-Gal inter-
nalization mediated by pep-1 vs. pep-1CF (Fig. 4). When the
Fig. 3. Kinetics of Pep-1CF uptake in HeLa cells: (A) in free form or
(B) complexed with b-Gal at 37 C (white circles) or 4 C (black
circles). Internalization was followed by means of ﬂuorescence
emission (If) dequenching of CF. Peptide internalization into cells
leads to ﬂuorescence recovery due to inaccessibility to TB (quencher).
The relative ﬂuorescence intensity, If/I0 (I0 is the ﬂuorescence intensity
in the absence of TB) was normalized at t = 0.
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diﬀerences between 4 and 37 C [7]. However, eﬃciency was
diﬀerent for the labelled and unlabelled peptides (Fig. 4),Fig. 4. Delivery of b-Gal into HeLa cells at 37 C, followed by
enzymatic production of 4-UM, mediated by pep-1CF (white circles)
or by pep-1 (black circles).revealing that the hydrophilic domain of the peptide is of crit-
ical importance for translocation.
We analysed the enzyme activity, in vitro, in free and in
complexed forms. The determined v0 of b-Gal are:
19.18 ± 0.24 lM/min for free form; 11.60 ± 0.53 lM/min when
complexed with unlabelled-pep-1 and 19.61 ± 0.38 lM/min in
the complex with pep-1CF. The presence of pep-1 reduces
the activity of the enzyme (in agreement with [7]), but this does
not hold for pep-1CF. This suggests that the pep-1CF does not
interact as strongly with the protein, which is an additional
eﬀect induced by the presence of CF in the Lys-rich domain.
This supports the hypothesis that pep-1 interacts with the car-
go both by means of hydrophobic and electrostatic interac-
tions [7].
The mechanism of translocation of pep-1CF is diﬀerent from
the one identiﬁed previously for pep-1. A simple physical
mechanism mediated by electrostatic interaction between
pep-1 and membrane is supported by diﬀerent sets of experi-
mental data [7,11]. However, Pep-1CF follows a diﬀerent path-
way, dependent on temperature, i.e., endocytic.
It should be stressed that pep-1CF has translocation ability
via physical (non-endocytic) processes (Fig. 2), however, such
ability is clearly decreased compared to unlabelled pep-1
(Fig. 2), in agreement with its smaller partition into mem-
branes. At 4 C, the low cell membrane ﬂuidity also contrib-
utes to inhibit physical translocation of pep-1CF. It is only
at 37 C that the endocytic pathway becomes an alternative
to the physical process and translocation occurs. A small
contribution of the endocytic pathway for translocation of
unlabelled pep-1 at 37 cannot be discarded, although a phys-
ical process is clearly dominant [7,11].
A reduced protein-uptake mediated by pep-1CF is due, not
only, to a decrease in translocation eﬃciency but also to a
diminished interaction of the pep-1CF with b-Gal.
3.5. Conclusion
Translocation of pep-1 is mediated by a physical process
governed by electrostatic interactions [7,11]. Modiﬁcation of
the hydrophilic domain, with a CF group, extensively de-
creases the aﬃnity of pep-1 for phospholipid membranes and
for the cargo macromolecule, which aﬀects the translocation
of the peptide alone as well as its capacity as delivery agent.
It was recently proposed that labelling CPPs inﬂuence the ﬁnal
location inside the cell [5]. We now generalize this diﬀerence to
a decrease in the extension of internalization and to a change
in the main mechanism of translocation. A small chemical
modiﬁcation of these sequences may modify the translocation
eﬃciency and even its pathway. It is worth mention that oligo-
Arg peptides have translocation ability on their own [22] with
no need for ‘‘hydrophobic’’ sequences.
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